Cilastatin for acute kidney injury

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 21 Feb 2025: Trial started, NCT07229040
  2. 14 Nov 2025: Trial registered, NCT07229040

The trials

NCT07229040: A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patients Undergoing Debulking Surgery With Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Cisplatin.

State
Under way
Phase
Phase 2
People
90 planned
Started
21 Feb 2025
Primary completion
21 Oct 2028
Arms
cilastatin
Results
None posted
  1. 21 Feb 2025: Trial started
  2. 14 Nov 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as cilastatine.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.